Factor XIa inhibitors: A review of the patent literature.
about
Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile.Discovery methods of coagulation-inhibiting drugs.First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.Fragment-Based Lead Generation of 5-Phenyl-1-pyrazole-3-carboxamide Derivatives as Leads for Potent Factor Xia Inhibitors
P2860
Factor XIa inhibitors: A review of the patent literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factor XIa inhibitors: A review of the patent literature.
@en
Factor XIa inhibitors: A review of the patent literature.
@nl
type
label
Factor XIa inhibitors: A review of the patent literature.
@en
Factor XIa inhibitors: A review of the patent literature.
@nl
prefLabel
Factor XIa inhibitors: A review of the patent literature.
@en
Factor XIa inhibitors: A review of the patent literature.
@nl
P2860
P1476
Factor XIa inhibitors: A review of the patent literature.
@en
P2093
Umesh R Desai
P2860
P304
P356
10.1517/13543776.2016.1154045
P407
P577
2016-02-16T00:00:00Z